Piérard-Franchimont C, Piérard G E
Service de Dermatopathologie, CHU de Liège, Belgique.
Rev Med Liege. 2012 Feb;67(2):64-8.
Treating a patient with cutaneous malignant melanoma relies on the recognition of a clever stratification of the distinct stages of the disease. The histoprognostic criteria were recently revisited. In addition, translational research fueled the development of new treatments with at last increased efficacy in the metastatic stage. Such therapeutic advance improves the median overall survival for a few months. Some combined treatments could possibly boost the beneficial effects.
治疗皮肤恶性黑色素瘤患者依赖于对该疾病不同阶段进行明智分层的认识。组织预后标准最近得到了重新审视。此外，转化研究推动了新治疗方法的发展，最终提高了转移性阶段的疗效。这种治疗进展将中位总生存期提高了几个月。一些联合治疗可能会增强有益效果。
